Sort
17,054 grants matching “genome editing”
Epigenetic Control of Nephron Progenitor Cell Lifespan
$371,806Samir S El-Dahr · Tulane University Of Louisiana · R01 · FY2018 · DK
Telomere dysfunction induced breast cancer pathogenesis
$371,660Sandy S Chang · Yale University · R01 · FY2019 · CA
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2
$371,660David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
A Resource Center for Tetrahymena Thermophila
$371,464Theodore G Clark · Cornell University · P40 · FY2019 · OD
BioGPS: Extensible Web 2.0 gene portal for structured and unstructured annotation
$371,458Andrew I Su · Scripps Research Institute, The · R01 · FY2012 · GM
BioGPS: Extensible Web 2.0 gene portal for structured and unstructured annotation
$371,458Andrew I Su · Scripps Research Institute, The · R01 · FY2011 · GM
Mechanisms and Applications of CRISPR-Cas Enzymes
$371,446M. Elizabeth Stroupe · Florida State University · R01 · FY2023 · GM
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer
$371,329Remi Buisson · University Of California-Irvine · R37 · FY2022 · CA
Hox genes regulate functionally distinct, regionally restricted MSC populations
$371,325Deneen M Wellik · University Of Wisconsin-Madison · R61 · FY2019 · AR
Development of a novel therapeutic strategy for treatment of SOD1-linked ALS by CRISPR/Cas9-mediated SOD1 promoter editing
$371,300Han-Xiang Deng · Northwestern University At Chicago · R01 · FY2020 · NS
Genomics Core- Bustamante
$371,296Carlos D. Bustamante · Stanford University · U54 · FY2019 · MD
Developmental Funds
$371,170Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Genetics of stroke vulnerability in C57BL/6 mouse substrains
$371,109Thaddeus S. Nowak · University Of Tennessee Health Sci Ctr · R01 · FY2023 · NS
Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid
$371,100Madhavan P Nair · Florida International University · R01 · FY2021 · DA
Genome editing, mRNA suppression and chain termintion as therapy for Lafora Epilepsy
$371,053Berge A Minassian · University Of Kentucky · P01 · FY2017 · NS
Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid
$370,861Madhavan P Nair · Florida International University · R01 · FY2022 · DA
Cellular and molecular transport in mucus
$370,822W Mark Saltzman · Yale University · R01 · FY2017 · EB
Regulation of retrotransposable element activity in Drosophila.
$370,814Stephen L. Helfand · Brown University · P01 · FY2020 · AG
Development of an intelligent droplet acoustofluidic platform for automated liquid-liquid handing and monitoring in biomedical research
$370,783Feng Guo · Trustees Of Indiana University · R01 · FY2025 · GM
P0531582 Oksenberg/Hollenbach R01NS102153 Supplement
$370,740Jorge R. Oksenberg · University Of California, San Francisco · R01 · FY2018 · NS
Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer
$370,707Gustavo Rodriguez · Endeavor Health Clinical Operations · R01 · FY2018 · CA
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC
$370,664Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2023 · CA
Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid
$370,610Madhavan P Nair · Florida International University · R01 · FY2023 · DA
CLL clonal evolution and the development of therapy-driven resistance
$370,572Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
$370,500Xinshu Grace Xiao · University Of California Los Angeles · R01 · FY2024 · CA